(Q74486539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

1 reference

1 reference

8

M Slaoui

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

S Thoelen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Van Damme

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Mathei

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Leroux-Roels

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

I Desombere

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Safary

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Vandepapeliere

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Meheus

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

708-714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

Hepatitis B vaccine boosting: the debate continues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900254-5

7 January 2021

10.1016/S0264-410X(97)00254-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference